Delivery Order SPE2DB22D3301-SPE2DB25FY6JB

Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $15,018.36 and is a firm-fixed-price delivery order with a completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $28,218.97 and a completion date of May 30, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.06 firm-fixed-price delivery order is for the supply of 380 mg VIVITROL vials and diluents. The award has a completion date of May 14, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $2,106.43 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract is funded by the Defense Logistics Agency, a defense agency, and has a completion date of May 23, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 mg vials and diluents. The contract, valued at $13,757.13, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for delivery through April 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Delivery Order valued at $2,418.54. The contract has an ultimate completion date of April 23, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract, valued at $7,635.39, is a firm fixed-price delivery order with a period of performance through November 2023. The contract was awarded on November 22, 2023, and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is for the delivery of VIVITROL 380 MG VIAL-DILUENTS medical supplies. The contract, valued at $12,296.96, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical under Delivery Order SPE2DX15D1053|SPE2DX25F6FQB. This is a firm fixed-price contract with a completion date of January 2, 2025. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY6JB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) involves the delivery of Vivitrol 380 mg vials and diluents. The $16,578.92 firm fixed-price delivery order contract has a period of performance through June 17, 2025. Amerisourcebergen Drug Corp is an established pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December 2026. This award is not designated as a set-aside contract, indicating open competition. The contract supports federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/15/25, 9:55 AM